BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING PROPIONATE CATABOLISM
申请人:Synlogic, Inc.
公开号:EP3328988A1
公开(公告)日:2018-06-06
US4332734A
申请人:——
公开号:US4332734A
公开(公告)日:1982-06-01
US4525577A
申请人:——
公开号:US4525577A
公开(公告)日:1985-06-25
[EN] BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING PROPIONATE CATABOLISM<br/>[FR] BACTÉRIES MODIFIÉES POUR TRAITER LES TROUBLES IMPLIQUANT LE CATABOLISME DU PROPIONATE
申请人:SYNLOGIC INC
公开号:WO2017023818A1
公开(公告)日:2017-02-09
The present disclosure provides engineered bacterial cells comprising a heterologous gene encoding a propionate catabolism enzyme. In another aspect, the engineered bacterial cells further comprise at least one heterologous gene encoding a transporter of propionate or a kill switch. The disclosure further provides pharmaceutical compositions comprising the engineered bacteria, and methods for treating disorders involving the catabolism of propionate, such as Propionic Acidemia and Methylmalonic Acidemia, using the pharmaceutical compositions.
Structure of the Adduct of 3-Methyl-2-cyclohexenone and Ethyl Cyanoacetate. The Question of “Meta”- and “Para”-Bridged Rings
作者:P. R. Shafer、William E. Loeb、William S. Johnson